Literature DB >> 20583252

Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: in vitro and in vivo studies.

Xavier Ragàs1, Tianhong Dai, George P Tegos, Montserrat Agut, Santi Nonell, Michael R Hamblin.   

Abstract

BACKGROUND AND
OBJECTIVE: Phenothiazinium dyes have been reported to be effective photosensitizers inactivating a wide range of microorganisms in vitro after illumination with red light. However, their application in vivo has not extensively been explored. This study evaluates the bactericidal activity of phenothiazinium dyes against multidrug-resistant Acinetobacter baumannii both in vitro and in vivo. STUDY DESIGN/
MATERIALS AND METHODS: We report the investigation of toluidine blue O, methylene blue, 1,9-dimethylmethylene blue, and new methylene blue for photodynamic inactivation of multidrug-resistant A. baumannii in vitro. The most effective dye was selected to carry out in vivo studies using third-degree mouse burns infected with a bioluminescent A. baumannii strain, upon irradiation with a 652 nm noncoherent light source. The mice were imaged daily for 2 weeks to observe differences in the bioluminescence-time curve between the photodynamic therapy (PDT)-treated mice in comparison with untreated burns.
RESULTS: All the dyes were effective in vitro against A. baumannii after 30 J/cm(2) irradiation of 635 or 652 nm red light had been delivered, with more effective killing when the dye remained in solution. New methylene blue was the most effective of the four dyes, achieving a 3.2-log reduction of the bacterial luminescence during PDT in vivo after 360 J/cm(2) and an 800 microM dye dose. Moreover, a statistically significant reduction of the area under the bioluminescence-time curve of PDT-treated mice was observed showing that the infection did not recur after PDT.
CONCLUSIONS: Phenothiazinium dyes, and especially new methylene blue, are potential photosensitizers for PDT to treat burns infected with multidrug-resistant A. baumannii in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20583252      PMCID: PMC2935797          DOI: 10.1002/lsm.20922

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  38 in total

Review 1.  Why are we afraid of Acinetobacter baumannii?

Authors:  Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2008-06       Impact factor: 5.091

2.  Photodynamic therapy for Acinetobacter baumannii burn infections in mice.

Authors:  Tianhong Dai; George P Tegos; Zongshun Lu; Liyi Huang; Timur Zhiyentayev; Michael J Franklin; David G Baer; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

3.  Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells.

Authors:  T Maisch; C Bosl; R-M Szeimies; N Lehn; C Abels
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  Effect of Ca+ on the photobactericidal efficacy of methylene blue and toluidine blue against gram-negative bacteria and the dye affinity for lipopolysaccharides.

Authors:  Marina N Usacheva; Matthew C Teichert; Chet E Sievert; Merrill A Biel
Journal:  Lasers Surg Med       Date:  2006-12       Impact factor: 4.025

Review 5.  Acinetobacter baumannii: an emerging multidrug-resistant threat.

Authors:  Thomas D Gootz; Andrea Marra
Journal:  Expert Rev Anti Infect Ther       Date:  2008-06       Impact factor: 5.091

Review 6.  Optimizing therapy for Acinetobacter baumannii.

Authors:  Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2007-12       Impact factor: 3.119

7.  Comparison of toluidine blue-mediated photodynamic therapy and conventional scaling treatment for periodontitis in rats.

Authors:  Y L Qin; X L Luan; L J Bi; Y Q Sheng; C N Zhou; Z G Zhang
Journal:  J Periodontal Res       Date:  2008-04       Impact factor: 4.419

8.  Antimicrobial photodynamic efficacy of side-chain functionalized benzo[a]phenothiazinium dyes.

Authors:  Sarika Verma; Ulysses W Sallum; Humra Athar; Lauren Rosenblum; James W Foley; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2008-07-23       Impact factor: 3.421

9.  Extensively drug-resistant Acinetobacter baumannii.

Authors:  Yohei Doi; Shahid Husain; Brian A Potoski; Kenneth R McCurry; David L Paterson
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

10.  In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agent.

Authors:  Parjam S Zolfaghari; Samantha Packer; Mervyn Singer; Sean P Nair; Jon Bennett; Cale Street; Michael Wilson
Journal:  BMC Microbiol       Date:  2009-02-04       Impact factor: 3.605

View more
  30 in total

1.  Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice.

Authors:  Tianhong Dai; Vida J Bil de Arce; George P Tegos; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Optimal photosensitizers for photodynamic therapy of infections should kill bacteria but spare neutrophils.

Authors:  Masamitsu Tanaka; Manabu Kinoshita; Yasuo Yoshihara; Nariyoshi Shinomiya; Shuhji Seki; Koichi Nemoto; Takahiro Hirayama; Tianhong Dai; Liyi Huang; Michael R Hamblin; Yuji Morimoto
Journal:  Photochem Photobiol       Date:  2011-10-31       Impact factor: 3.421

3.  Potentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide: in vitro and in vivo studies.

Authors:  Yunsong Zhang; Tianhong Dai; Min Wang; Daniela Vecchio; Long Y Chiang; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2015-03       Impact factor: 5.307

Review 4.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

Review 5.  Photosensitizers in antibacterial photodynamic therapy: an overview.

Authors:  Jaber Ghorbani; Dariush Rahban; Shahin Aghamiri; Alireza Teymouri; Abbas Bahador
Journal:  Laser Ther       Date:  2018-12-31

Review 6.  Antimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyond.

Authors:  Fatma Vatansever; Wanessa C M A de Melo; Pinar Avci; Daniela Vecchio; Magesh Sadasivam; Asheesh Gupta; Rakkiyappan Chandran; Mahdi Karimi; Nivaldo A Parizotto; Rui Yin; George P Tegos; Michael R Hamblin
Journal:  FEMS Microbiol Rev       Date:  2013-07-25       Impact factor: 16.408

7.  Antimicrobial photodynamic therapy against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumannii.

Authors:  Mirian Marcolan De Mello; Patrícia Pimentel De Barros; Renata de Cassia Bernardes; Silvio Rubens Alves; Naiara Pires Ramanzini; Lívia Mara Alves Figueiredo-Godoi; Ana Carolina Chipoletti Prado; Antonio Olavo Cardoso Jorge; Juliana Campos Junqueira
Journal:  Lasers Med Sci       Date:  2019-03-20       Impact factor: 3.161

8.  Novel Broad-Spectrum Antimicrobial Photoinactivation of In Situ Oral Biofilms by Visible Light plus Water-Filtered Infrared A.

Authors:  L Karygianni; S Ruf; M Follo; E Hellwig; M Bucher; A C Anderson; K Vach; A Al-Ahmad
Journal:  Appl Environ Microbiol       Date:  2014-09-19       Impact factor: 4.792

9.  Study of photodynamic therapy in the control of isolated microorganisms from infected wounds--an in vitro study.

Authors:  Denise Pereira de Lima Carvalho; Juliana Guerra Pinto; Camila Di Paula Costa Sorge; Fabiana Regis Rodrigues Benedito; Sonia Khouri; Juliana Ferreira Strixino
Journal:  Lasers Med Sci       Date:  2013-03-01       Impact factor: 3.161

10.  Eradication of multidrug-resistant pseudomonas biofilm with pulsed electric fields.

Authors:  Gaddi Blumrosen; Daniela Vecchio; Saiqa I Khan; Alexander Golberg; Michael C McCormack; Martin L Yarmush; Michael R Hamblin; William G Austen
Journal:  Biotechnol Bioeng       Date:  2015-09-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.